ELANTAS Beck India Résultats passés
Passé contrôle des critères 3/6
ELANTAS Beck India has been growing earnings at an average annual rate of 25.1%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 15.2% per year. ELANTAS Beck India's return on equity is 18.2%, and it has net margins of 20.1%.
Informations clés
25.1%
Taux de croissance des bénéfices
25.1%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 17.7% |
| Taux de croissance des recettes | 15.2% |
| Rendement des fonds propres | 18.2% |
| Marge nette | 20.1% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Ventilation des recettes et des dépenses
Comment ELANTAS Beck India gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 7,307 | 1,468 | 449 | 0 |
| 30 Jun 24 | 7,104 | 1,506 | 429 | 0 |
| 31 Mar 24 | 6,923 | 1,442 | 413 | 0 |
| 31 Dec 23 | 6,852 | 1,373 | 406 | 0 |
| 30 Sep 23 | 6,709 | 1,268 | 368 | 0 |
| 30 Jun 23 | 6,646 | 1,190 | 423 | 0 |
| 31 Mar 23 | 6,622 | 1,041 | 400 | 0 |
| 31 Dec 22 | 6,490 | 978 | 383 | 0 |
| 30 Sep 22 | 6,256 | 879 | 334 | 0 |
| 30 Jun 22 | 6,054 | 805 | 319 | 0 |
| 31 Mar 22 | 5,494 | 725 | 318 | 0 |
| 31 Dec 21 | 5,222 | 669 | 312 | 0 |
| 30 Sep 21 | 4,947 | 728 | 313 | 0 |
| 30 Jun 21 | 4,759 | 744 | 306 | 0 |
| 31 Mar 21 | 4,072 | 666 | 291 | 0 |
| 31 Dec 20 | 3,833 | 618 | 283 | 0 |
| 30 Sep 20 | 3,585 | 498 | 272 | 0 |
| 30 Jun 20 | 3,400 | 428 | 274 | 0 |
| 31 Mar 20 | 4,008 | 509 | 279 | 0 |
| 31 Dec 19 | 3,941 | 496 | 276 | 0 |
| 30 Sep 19 | 4,122 | 534 | 264 | 0 |
| 30 Jun 19 | 4,160 | 500 | 257 | 0 |
| 31 Mar 19 | 4,107 | 493 | 247 | 0 |
| 31 Dec 18 | 4,094 | 658 | 258 | 0 |
| 30 Sep 18 | 3,974 | 658 | 249 | 0 |
| 30 Jun 18 | 3,896 | 684 | 247 | 0 |
| 31 Mar 18 | 3,805 | 688 | 244 | 0 |
| 31 Dec 17 | 3,827 | 551 | 227 | 0 |
| 30 Sep 17 | 3,696 | 522 | 249 | 0 |
| 30 Jun 17 | 3,695 | 542 | 239 | 0 |
| 31 Mar 17 | 3,746 | 560 | 227 | 0 |
| 31 Dec 16 | 3,658 | 545 | 224 | 0 |
| 30 Sep 16 | 3,647 | 526 | 208 | 0 |
| 30 Jun 16 | 3,594 | 480 | 203 | 0 |
| 31 Mar 16 | 3,537 | 466 | 205 | 0 |
| 31 Dec 15 | 3,447 | 418 | 210 | 0 |
| 30 Sep 15 | 3,456 | 408 | 381 | 10 |
| 30 Jun 15 | 3,480 | 375 | 379 | 10 |
| 31 Mar 15 | 3,419 | 342 | 379 | 10 |
| 31 Dec 14 | 3,411 | 316 | 193 | 0 |
| 30 Sep 14 | 3,313 | 296 | 301 | 0 |
| 30 Jun 14 | 3,180 | 285 | 301 | 0 |
| 31 Mar 14 | 3,085 | 285 | 296 | 0 |
| 31 Dec 13 | 3,045 | 318 | 303 | 9 |
Des revenus de qualité: 500123 has a large one-off gain of ₹415.1M impacting its last 12 months of financial results to 30th September, 2024.
Augmentation de la marge bénéficiaire: 500123's current net profit margins (20.1%) are higher than last year (18.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 500123's earnings have grown significantly by 25.1% per year over the past 5 years.
Accélération de la croissance: 500123's earnings growth over the past year (15.8%) is below its 5-year average (25.1% per year).
Bénéfices par rapport au secteur d'activité: 500123 earnings growth over the past year (15.8%) exceeded the Chemicals industry 10.4%.
Rendement des fonds propres
ROE élevé: 500123's Return on Equity (18.2%) is considered low.